h1

001008078 001__ 1008078
001008078 005__ 20251001135038.0
001008078 0247_ $$2HSB$$aeva591653
001008078 0247_ $$2ISSN$$a1664-3224
001008078 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85195372662
001008078 0247_ $$2WOS$$aWOS:001227475000001
001008078 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-254468
001008078 0247_ $$2doi$$a10.3389/fimmu.2024.1384509
001008078 0247_ $$2pmid$$apmid:38846951
001008078 037__ $$aRWTH-CONV-254468
001008078 041__ $$aEnglish
001008078 1001_ $$aBoklund, Tobias Idor$$b0$$eCorresponding author
001008078 245__ $$aMathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms$$honline
001008078 260__ $$aLausanne$$bFrontiers Media$$c2024
001008078 3367_ $$00$$2EndNote$$aJournal Article
001008078 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001008078 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
001008078 3367_ $$2BibTeX$$aARTICLE
001008078 3367_ $$2DRIVER$$aarticle
001008078 3367_ $$2DataCite$$aOutput Types/Journal article
001008078 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001008078 591__ $$aDenmark
001008078 591__ $$aGermany
001008078 7001_ $$aSnyder, Jordan$$b1
001008078 7001_ $$aGudmand-Hoeyer, Johanne$$b2
001008078 7001_ $$aLarsen, Morten Kranker$$b3
001008078 7001_ $$aKnudsen, Trine Alma$$b4
001008078 7001_ $$aEickhardt-Dalbøge, Christina Schjellerup$$b5
001008078 7001_ $$aSkov, Vibe$$b6
001008078 7001_ $$aKjær, Lasse$$b7
001008078 7001_ $$aHasselbalch, Hans C.$$b8
001008078 7001_ $$aAndersen, Morten$$b9
001008078 7001_ $$aOttesen, Johnny T.$$b10
001008078 7001_ $$0P:(DE-82)IDM06393$$aStiehl, Thomas Peter$$b11$$urwth
001008078 770__ $$aMathematical Modeling and Computational Predictions in Oncoimmunology / Editors: Vladimir A Kuznetsov, Heiko Enderling, Mark Chaplain
001008078 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2024.1384509$$p1-17$$tFrontiers in immunology$$v15$$x1664-3224
001008078 8564_ $$uhttps://publications.rwth-aachen.de/record/1008078/files/1008078.pdf$$yOpenAccess
001008078 909CO $$ooai:publications.rwth-aachen.de:1008078$$pVDB$$pdnbdelivery$$pdriver$$popen_access$$popenaire
001008078 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06393$$aRWTH Aachen$$b11$$kRWTH
001008078 9141_ $$y2024
001008078 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001008078 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001008078 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2022$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-12-29T15:23:07Z
001008078 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-12-29T15:23:07Z
001008078 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001008078 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-28
001008078 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2022$$d2024-12-28
001008078 9201_ $$0I:(DE-82)929420_20210202$$k929420$$lInstitut und Lehr- und Forschungsgebiet Disease Modelling mit Schwerpunkt auf Phasenübergängen zwischen Phänotypen$$x0
001008078 961__ $$z2025-03-20
001008078 970__ $$aeva591653
001008078 9801_ $$aFullTexts
001008078 980__ $$aI:(DE-82)929420_20210202
001008078 980__ $$aUNRESTRICTED
001008078 980__ $$aVDB
001008078 980__ $$acontb
001008078 980__ $$ajournal